Zepbound vs Semaglutide vs Wegovy: What’s the Difference?
Zepbound is a medication designed to reduce food cravings and promote weight loss by targeting the brain’s appetite control center. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that regulates blood sugar levels and promotes weight loss by reducing appetite and increasing feelings of fullness. Wegovy is a higher-dose formulation of semaglutide specifically approved for chronic weight management in adults with obesity or overweight. While Zepbound focuses on appetite control, semaglutide and Wegovy offer multifaceted approaches targeting appetite regulation and metabolic function. For more information, contact us or schedule an appointment online. We have convenient locations to serve you in Folsom, CA and Roseville, CA.
Table of Contents:
What is zepbound?
What is the difference between semaglutide, Zepbound, and Wegovy?
What are zepbound, semaglutide, and Wegovy approved for?
Which one is better for weight loss?
Zepbound is a brand-name prescription medication that is used for chronic weight management in adults. Zepbound has the same active ingredient as Mounjaro, a medication used to manage type 2 diabetes. Both Zepbound and Mounjaro contain tirzepatide, which mimics the actions of two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
In clinical trials, participants using Zepbound achieved an average weight loss of 15% to 21% of their body weight, depending on the dosage. This medication offers a variety of benefits for those who want to improve their wellness and prevent the risk of serious health concerns associated with obesity. These include improved glycemic control, reduced cravings, and lower risk of cardiovascular events.
Zepbound is administered through a subcutaneous injection once a week. To achieve the most desirable results, Zepbound should be used in conjunction with a reduced-calorie diet and increased physical activity. To learn more about Zepbound and whether you are a good candidate for this treatment, schedule an appointment with a medical professional to discuss your weight loss goals, your medical history, and your lifestyle.
Semaglutide, Zepbound, and Wegovy are all medications that are used for weight management; however, there are differences between these treatment options. The first thing to understand when distinguishing between these medications is that semaglutide is sold under the brand names Ozempic and Wegovy.
Zepbound, on the other hand, contains the active ingredient tirzepatide. Tirzepatide has similar effects to semaglutide; however, it acts as a dual agonist of the GLP-1 and GIP receptors. While semaglutide (Wegovy/Ozempic) acts solely as a GLP-1 receptor agonist, Zepbound provides a more comprehensive approach to weight loss and management.
Both tirzepatide and semaglutide-based medications can promote significant and sustainable weight loss. To determine which of these medications is best for your circumstances, schedule a consultation with a reputable weight management specialist near you.
To successfully distinguish between the various prescription medications available for weight loss and management, it’s crucial to understand what each medication is specifically approved for. Semaglutide, which is marketed under brand names such as Ozempic and Wegovy, gained FDA approval for both the treatment of type 2 diabetes (Ozempic) and chronic weight management (Wegovy).
Zepbound, a tirzepatide-based medication, was approved by the FDA in 2023 for chronic weight management in adults with obesity. There is also another tirzepatide-based medication, Mounjaro, which is approved for the management of type 2 diabetes but may be prescribed off-label for weight management to individuals who align with certain criteria.
Beyond their usefulness for weight loss and management, these medications offer additional health and wellness benefits. For instance, people taking these medications often experience improvements in heart health, such as lower blood pressure and cholesterol levels. This makes semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro) not only effective for weight loss and diabetes management but also beneficial for overall wellness.
When comparing Zepbound (tirzepatide) and Wegovy (semaglutide) for weight management, it’s important to consider the distinctions between them. Wegovy has shown impressive results, with participants losing an average of 15% of their starting body weight in clinic trials. This medication works by regulating appetite to reduce calorie intake, making it highly effective for those who want to achieve and maintain their weight loss goals.
Zepbound is also a powerful weight management option, due to its dual action on GLP-1 and GIP receptors to enhance weight loss. Due to this, Zepbound may result in greater weight loss than Wegovy, though the two medications work in similar ways in terms of regulating appetite and minimizing cravings.
To learn more about your weight management options and have your questions answered, schedule a consultation with a knowledgeable providers near you. If you are in or near Folsom, California, the experts at Set Point Medical Weight Loss Clinic can provide top-quality care to support you on your weight loss journey and help you achieve enhanced wellness. For more information, contact us or schedule an appointment online. We have convenient locations to serve you in Folsom, CA and Roseville, CA. We serve patients from Folsom CA, Roseville CA, El Dorado Hills CA, Citrus Heights CA, Fair Oaks CA, Granite Bay CA, Rocklin CA, Rancho Cordova CA, Loomis CA, and surrounding areas.
Additional Services You May Need
▸ Tirzepatide
▸ Weight Loss
▸ Semaglutide
▸ Body Contouring
▸ Red Light Therapy